Genetic biomarker linked to subcutaneous growth hormone dose-response
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Genetic biomarker linked to subcutaneous growth hormone dose-response...

Dental Referrals By Primary Care Physicians
Young children from low-income families experience high levels of tooth decay and face many barriers to getting dental treatment and preventive services. Because these children usually visit their pediatrician or other primary care provider far more frequently than a dentist, the primary care medical setting is gaining popularity
Dental Referrals By Primary Care Physicians...

CHMP Upholds Negative Opinion For The EU Application For Cimzia® In The Treatment Of Crohn’s Disease
UCB announced today that the European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) has rejected the appeal following CHMP refusal of the Marketing Authorization Application (MAA) for Cimzia® (certolizumab pegol) in the treatment of patients with Crohn’s disease, a chronic and debilitating inflammatory
CHMP Upholds Negative Opinion For The EU Application For Cimzia® In The Treatment Of Crohn’s Disease...

BDA Locks Horns With Department Of Health Over Unfair Notice Clause In Dentists’ Contracts, UK
The British Dental Association is to challenge a Department of Health legal appeal which if successful could result in dentists’ contracts being ended by primary care trusts (PCTs) on as little as one day’s notice and with no significant cause.
BDA Locks Horns With Department Of Health Over Unfair Notice Clause In Dentists’ Contracts, UK...